Jean-Patrick Demonsang
Chairman bij Demonsang Consulting SAS
Profiel
Jean-Patrick Demonsang is currently the Chairman of Demonsang Consulting SAS.
Previously, he served as the Chief Executive Officer of Genode Partners SAS, Chairman of G1j Ile De France, and Chairman of Parexi SAS.
From 2010 to 2013, he was the President & Managing Director of Seventure Partners SA. He also served as a Director at Natixis Venture Sélection SA and an Independent Director at Orphan Synergy Europe-Pharma SA. Demonsang holds an MBA from École des Hautes Études Commerciales de Paris.
Actieve functies van Jean-Patrick Demonsang
| Bedrijven | Functie | Begin |
|---|---|---|
| Demonsang Consulting SAS | Chairman | - |
Eerdere bekende functies van Jean-Patrick Demonsang
| Bedrijven | Functie | Einde |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director/Board Member | 22-06-2023 |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Chief Executive Officer | 01-01-2013 |
Natixis Venture Sélection SA
 Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Director/Board Member | - |
| Genode Partners SAS | Chief Executive Officer | - |
| Parexi SAS | Chairman | - |
Opleiding van Jean-Patrick Demonsang
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
Natixis Venture Sélection SA
Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Finance |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Demonsang Consulting SAS | |
| G1j Ile De France | |
| Parexi SAS | |
| Genode Partners SAS |
